Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer [Corrigendum]

Chang J,Hong L, Liu Y,Pan Y, Yang H,Ye W,Xu K, Li Z, Zhang S

Cancer Management and Research（2020）

引用 0|浏览0

暂无评分

摘要

Chang J, Hong L, Liu Y. Cancer Manag Res. 2020;12:2641–2651. The authors have advised that there is an error in Figure 2E on page 2646. The authors apologize for this error. Read the original article

查看译文

关键词

pik3cg,paclitaxel,claudin-low breast cancer,combined drugs,targeted therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要